Author

Katarzyna Behrendt

Institution: The Maria Sklodowska-Curie National Research Institute of Oncology

Observed institutions: Mount Vernon Hospital, Institut Gustave Roussy, MRC Clinical Trials Unit at UCL, The Maria Sklodowska-Curie National Research Institute of Oncology, University College London, Marie Curie, Medical Research Council

OpenAlex ID: A5111977420

Hyperfractionated or Accelerated Radiotherapy in Lung Cancer: An Individual Patient Data Meta-Analysis

2012 · Audrey Mauguen, Cécile Le Péchoux, et al. · Journal of Clinical Oncology · 246

Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer

2009 · Monika Pietrowska, Lukasz Marczak, et al. · Journal of Translational Medicine · 72

Mass spectrometry-based analysis of therapy-related changes in serum proteome patterns of patients with early-stage breast cancer

2010 · Monika Pietrowska, Joanna Polanska, et al. · Journal of Translational Medicine · 24

Alpha/beta (α/β) ratio for prostate cancer derived from external beam radiotherapy and brachytherapy boost

2016 · Philip S Boonstra, Jeremy MG Taylor, et al. · British Journal of Radiology · 14

The effectiveness and side effects of conformal external beam radiotherapy combined with high-dose-rate brachytherapy boost compared to conformal external beam radiotherapy alone in patients with prostate cancer

2015 · Beata Smolska-Ciszewska, Leszek Miszczyk, et al. · Radiation Oncology · 13

Salvage brachytherapy for local recurrences of prostate cancer treated previously with radiotherapy.

2009 · Marzena Gawkowska-Suwinska, Marek Fijałkowski, et al. · PubMed · 8

Pre-operative hyperfractionated concurrent radiochemotherapy for locally advanced rectal cancers: a phase II clinical study

2017 · Adam Idasiak, Katarzyna Galwas-Kliber, et al. · British Journal of Radiology · 6

Early closure of phase II prospective study on acute and late tolerance of hypofractionated radiotherapy in low-risk prostate cancer patients

2014 · Katarzyna Behrendt, Elżbieta Nowicka, et al. · Reports of Practical Oncology & Radiotherapy · 6

Tolerability and toxicity of prophylactic cranial irradiation in patients with non-small cell lung cancer – Results of a phase II study (with estimation of hematological toxicity, pituitary function and magnetic resonance spectra changes)

2014 · Marzena Gawkowska-Suwińska, Sławomir Blamek, et al. · Reports of Practical Oncology & Radiotherapy · 3

AMACR Detection in Urine Samples. Lack of Clinical Application in Routine Practice~!2010-02-11~!2010-06-23~!2010-08-26~!

2010 · Ewa Malusecka, Agnieszka Gogler, et al. · The Open Prostate Cancer Journal · 1

Clinical course of breast cancer in carriers of BRCA1 germline mutations

2003 · B. Utracka-Hutka, Dariusz Lange, et al. · Contemporary Oncology/Współczesna Onkologia · 1

Comparison of the quality of life of patients with prostate cancer who undergo radical treatment

2026 · Beata Smolska-Ciszewska, Sebastian Ciszewski, et al. · Research Square

[Nr 84] Radykalna radiochemioterapia raka odbytu u chorych powyżej siedemdziesiątego roku życia

2013 · Monika Giglok, Katarzyna Behrendt, et al. · Zeszyty Naukowe WCO Letters in Oncology Science

Early effectiveness and toxicity of intraluminal HDR brachytherapy in patients with lung cancer: preliminary experience of the Center of Oncology in Gliwice, Department of Brachytherapy

2004 · Marzena Gawkowska‐Suwińska, Marek Fijałkowski, et al. · Contemporary Oncology/Współczesna Onkologia

Works count: 14

Citation count: 394

H-index: 6

I10-index: 5